ACAD

ACADIA Pharmaceuticals Inc. Analyst PE Estimates

$13.79
*  
0.36
  negative  
2.54%
Get ACAD Alerts
*Delayed - data as of May 21, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
ACAD
ACADIA Pharmaceuticals Inc. NASDAQ-GM


Price/Earning Ratio
Price/Earnings Ratio is a widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period.

Data Provider: Data is provided by Zacks Investment Research